Many studies have documented the dangers of the traditional negative physical risk factors on health – excessive smoking, drinking and being overweight. But far less research has focused on less-tangible, positive influences -- the protective role of psychological and social supports.
Brain
Two children, both age 3, enroll in publicly funded preschool. But they may have vastly different experiences: One child may attend preschool for 8 hours a day and be taught by a teacher with a bachelor's degree while the other child may be in preschool for only a few hours a day, under the supervision of a teacher with a 2-year degree. Why is there so much variability and are these programs meeting their potential for adequately preparing youngsters for school?
A study led by a researcher at the University of California, San Diego School of Medicine indicates that parent-only treatments for childhood obesity work equally as well as plans that include parents and child, while at the same time more cost effective and potentially easier for families.
The results were published today in the advanced online edition of the journal Obesity.
(PHOENIX, AZ) -- Scientists at Barrow Neurological Institute have recently made discoveries about a type of cell that may limit inflammation in the central nervous system (CNS) – a finding that could have important implications in the treatment of brain disorders such as multiple sclerosis. The research, led by Barrow's Fu-Dong Shi, MD, PhD, was published in the August 2010 issue of The Journal of Experimental Medicine, and simultaneously highlighted in Nature.
Pathological protein deposits linked to Alzheimer's disease and cerebral amyloid angiopathy can be triggered not only by the administration of pathogenic misfolded protein fragments directly into the brain but also by peripheral administration outside the brain. This is shown in a new study done by researchers at the Hertie Institute of Clinical Brain Research (HIH, University Hospital Tübingen, University of Tübingen) and the German Center for Neurodegenerative Diseases (DZNE), to be published in Science on October 21, 2010.
CAMBRIDGE, Mass. - A new paper from MIT neuroscientists, in collaboration with Alvaro Pascual-Leone at Beth Israel Deaconess Medical Center, offers evidence that it is easier to rewire the brain early in life. The researchers found that a small part of the brain's visual cortex that processes motion became reorganized only in the brains of subjects who had been born blind, not those who became blind later in life.
People feel worse about a transgression that will take place in the future than an identical one that occurred in the past, according to new research from the University of Chicago Booth School of Business.
Thinking about future events tends to stir up more emotions than events in the past, said Eugene Caruso, an assistant professor of behavioral science at Chicago Booth who conducted the research which appeared recently in the Journal of Experimental Psychology: General.
A child who grows up in the midst of political conflict, such as war or terrorism, can exhibit severe emotional scars. But certain qualities, which psychologists call "resilience factors," can help overcome this adversity.
What do we mean by "common sense" when we talk about a disease? What affects the ideas and beliefs that patients have of their disease? Researchers at the University of Granada have developed a test for measuring and assessing chronic patients' cognitive representation of their disease. This advance will enable the development of clinical psychological treatments much more efficient than those currently employed.
MAYWOOD, Ill. -- A dozen new epilepsy drugs are giving doctors and patients more options, but making treatment decisions more complex, a Loyola epilepsy specialist reports in the journal Neurologic Clinics.
"Clinicians practice in an era of abundance of anti-epileptic drugs," Dr. Jorge J. Asconapé wrote. The new drugs provide "an opportunity to better meet the needs of more patients."
Asconapé's article will appear in the November issue of Neurologic Clinics, now available online.
A University of Washington Medical Center patient on Thursday, Oct. 21, will be the world's first recipient of a device that aims to quell the disabling vertigo associated with Meniere's disease.
In the brain, dopamine is involved in a number of processes that control the way we behave. If an action results in the substance being released, we are more likely to repeat the action. This applies to actions such as eating, sexual intercourse or winning a competition. However, the same also holds true when individuals take harmful narcotics. Scientists believe that mental illnesses such as schizophrenia can be linked to dopamine imbalances.
Learning signal
WASHINGTON, Oct. 20 -- Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.
NEW YORK (Oct. 20, 2010) -- In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.
A common infection in children, strep throat can lead to problems with a child's heart, joints or brain if left untreated. And when the brain is involved, motor and mental functioning may be compromised, leading to syndromes such as attention deficit disorder and obsessive-compulsive disorder (OCD).